NCT07287098 2026-04-17
preEMBER
Eli Lilly and Company
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT05509790 2026-04-13
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
Eli Lilly and Company
Phase 1 Active not recruiting
NCT05514054 2026-04-02
EMBER-4
Eli Lilly and Company
Phase 3 Active not recruiting
NCT05307705 2026-03-27
PIKASSO-01
Eli Lilly and Company
Phase 1 Active not recruiting
NCT07410559 2026-02-18
Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer
Fudan University
Phase 2 Not yet recruiting